Concepedia

Richard Söll

RS

Statistics

Publications

59

Citations

5K

H-Index

28

Active since

1970

Affiliations

WuXi AppTec (China)(Current)

BioPredict (United States)

Scripps Research Institute

Harvard University

Mayo Clinic in Arizona

Richard Söll is an author at WuXi AppTec (China) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1970–2023

59

Publications

59

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Alex Zhavoronkov, Yan A. Ivanenkov, Alex Aliper et al. · Nature Biotechnology · 2019 · 1.5K citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera

Gerlinde Wernig, Michael G. Kharas, Rachel Okabe et al. · Cancer Cell · 2008 · 384 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction

Sara M. Weis, Satoshi Shintani, Alberto Weber et al. · Journal of Clinical Investigation · 2004 · 322 citations · Full text

Medicine, Cardiology, Cell Biology +17

Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction

Sara M. Weis, Satoshi Shintani, Alberto Weber et al. · Journal of Clinical Investigation · 2004 · 298 citations · Full text

Medicine, Cardiology, Cell Biology +17

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

Animesh Pardanani, John Hood, Terra L. Lasho et al. · Leukemia · 2007 · 284 citations

Life Sciences, Molecular Biology, Pharmacotherapy +10

1–5 of 59